# Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis

> **NCT03426969** · EARLY_PHASE1 · COMPLETED · sponsor: **M.D. Anderson Cancer Center** · enrollment: 3 (actual)

## Conditions studied

- Primary Myelofibrosis
- Secondary Myelofibrosis

## Interventions

- **DRUG:** Cyclophosphamide
- **BIOLOGICAL:** Filgrastim
- **DRUG:** Fludarabine Phosphate
- **PROCEDURE:** Hematopoietic Cell Transplantation
- **DRUG:** Melphalan
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Tacrolimus
- **RADIATION:** Total-Body Irradiation

## Key facts

- **NCT ID:** NCT03426969
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-31
- **Primary completion:** 2020-09-21
- **Final completion:** 2020-09-21
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2020-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03426969

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03426969, "Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03426969. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*